Castleman Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have an appointment or are staying as a patient at UNC Cancer Hospitals, an affiliated clinic, or one of the participating locations for the assessment or treatment of a plasma cell disorder.
- You have been diagnosed with a plasma cell disorder, which means a condition where abnormal proteins or abnormal plasma cells are found in your body — examples include MGUS, smoldering myeloma, multiple myeloma, amyloidosis, POEMS syndrome, and similar conditions.
- You are 18 years old or older.
- You are willing to take part in the study and agree to complete surveys or assessments at the start of the study and at later follow-up points.
- You are able to read and speak English.
Who may not be able to join:
- You have physical health problems, mental health conditions, or behavioral issues that your doctor feels would make it too difficult for you to take part in the study successfully.
Important note on eligibility checks:
- No special scans or blood tests are needed just to find out if you qualify for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sascha Tuchman, MD, UNC Lineberger Comprehensive Cancer Center
Phone: (919) 966-4432
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Creation of a Registry of Plasma Cell Disorder (PCD) patients; Completion of baseline and longitudinal assessments in PCD patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.